Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objectives The aim of this study was to project the long‐term costs and outcomes of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) in patients with Type 1 diabetes in the UK. Methods The CORE Diabetes Model is a peer‐reviewed, validated model which employs standard Markov/Monte Carlo simulation techniques to describe the long‐term incidence and progression of diabetes‐related complications. It was used to simulate disease progression in a cohort of patients with baseline characteristics taken from published UK studies (mean age 26 years, duration of diabetes 12 years, mean HbA 1c 8.68%). Direct costs for 2003 were calculated from a third‐party payer perspective. Discount rates of 3.0% per annum were applied to costs and clinical outcomes. Results Treatment with CSII was associated with an improvement in mean quality adjusted life expectancy (QALE) of 0.76 ± 0.19 years compared with MDI (12.03 ± 0.15 vs. 11.27 ± 0.14 years). Mean direct lifetime costs were £19 407 ± 1727 higher with CSII treatment compared with MDI (£80 511 ± 1257 vs. £61 104 ± 1249). This produced an incremental cost‐effectiveness ratio (ICER) of £25 648 per quality‐adjusted life year (QALY) gained with CSII vs. MDI. The results were most sensitive to variation in hypoglycaemia rates and altering improvements in HbA 1c associated with CSII therapy compared with MDI. Conclusions Improvements in glycaemic control associated with CSII over MDI led to improved QALE owing to reduced incidence of diabetes‐related complications. CSII was associated with an ICER of £25 648 per QALY gained vs. MDI, representing good value for money by current standards in the UK. Diabet. Med. (2005)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502
Psychological status of diabetic people with or without lower limb disability
Carrington, A. L., Mawdsley, S. K. V., Morley, M., Kincey, J., & Boulton, A. J. M. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01198-9 · Cited by 201
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Cummins, E., Royle, P., Snaith, A., Greene, A., Robertson, L., McIntyre, L., & Waugh, N. (2010) · Health Technology Assessment · doi:10.3310/hta14110 · Cited by 335
Metadata
- Authors
- Roze, S., Valentine, W. J., Zakrzewska, K. E., & Palmer, A. J.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2005-08-15
- Volume
- 22
- Issue
- 9
- Pages
- 1239-1245
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2017930048
- Cited by
- 96
- References
- 2
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01576.x
- The paper
- Roze, S., Valentine, W. J., Zakrzewska, K. E., & Palmer, A. J. (2005). Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01576.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.